Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Hypolipidemic effects of F-1394 in hyperlipidemic dogs

June 26, 1997

Potential new antidiabetic and antiobesity agent from Dainippon

June 26, 1997

Positive efficacy profile for MacroChem's erectile dysfunction therapy

June 26, 1997

Encouraging data reported for Sugen's insulin phosphatase inhibitors

June 26, 1997

Kyowa Hakko claims compounds for thrombocytopenia

June 26, 1997

Amylin and J&J expand product development program

June 25, 1997

Update on clinical progression of Amylin's diabetes drug

June 25, 1997

DuPont Merck seeks to license cholesterol-lowering agent

June 25, 1997

Hypocholesterolemic compounds reported by Schering-Plough

June 23, 1997

Promising results reported for Senetek's INVICORP for male erectile dysfunction

June 19, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 26, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Dual-targeting, rapamycin-enhanced CAR T for multiple myeloma
BioWorld Science
Umoja Biopharma Inc. performed preclinical studies to evaluate the antitumor activity of UB-VV500, an off-the-shell lentiviral vector CAR T-cell product. It is...